---
title: "Dencare released its 2024 annual performance, with a net profit attributable to the parent company of 161 million yuan, a year-on-year increase of 14.07%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236808875.md"
description: "Dencare released its 2024 annual performance, with operating revenue of 1.56 billion yuan, a year-on-year increase of 13.40%; net profit attributable to the parent company of 161 million yuan, a year-on-year increase of 14.07%; net profit excluding non-recurring gains and losses of 135 million yuan, a year-on-year increase of 27.07%. The basic earnings per share is 0.94 yuan, and it plans to distribute a cash dividend of 7.5 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-04-21T13:52:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236808875.md)
  - [en](https://longbridge.com/en/news/236808875.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236808875.md)
generator: "portal-rs"
---

# Dencare released its 2024 annual performance, with a net profit attributable to the parent company of 161 million yuan, a year-on-year increase of 14.07%

According to the Zhitong Finance APP, Dencare (001328.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 1.56 billion yuan, a year-on-year increase of 13.40%. The net profit attributable to shareholders of the listed company was 161 million yuan, a year-on-year increase of 14.07%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 135 million yuan, a year-on-year increase of 27.07%. The basic earnings per share were 0.94 yuan. It is proposed to distribute a cash dividend of 7.5 yuan (tax included) for every 10 shares to all shareholders

### Related Stocks

- [001328.CN](https://longbridge.com/en/quote/001328.CN.md)

## Related News & Research

- [12:10 ET10,000 COREWELL HEALTH EAST NURSES RATIFY FIRST TEAMSTERS CONTRACT](https://longbridge.com/en/news/296516959.md)
- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [Rapid Dose Therapeutics, Aavishkar win India patent for monolayer QuickStrip nicotine oral film](https://longbridge.com/en/news/296491705.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**